For: | Curry EL, Moad M, Robson CN, Heer R. Using induced pluripotent stem cells as a tool for modelling carcinogenesis. World J Stem Cells 2015; 7(2): 461-469 [PMID: 25815129 DOI: 10.4252/wjsc.v7.i2.461] |
---|---|
URL: | https://www.wjgnet.com/1948-0210/full/v7/i2/461.htm |
Number | Citing Articles |
1 |
George M. Ramzy, Thibaud Koessler, Eloise Ducrey, Thomas McKee, Frédéric Ris, Nicolas Buchs, Laura Rubbia-Brandt, Pierre-Yves Dietrich, Patrycja Nowak-Sliwinska. Patient-Derived In Vitro Models for Drug Discovery in Colorectal Carcinoma. Cancers 2020; 12(6): 1423 doi: 10.3390/cancers12061423
|
2 |
Ying Qu, Nur Yucer, Veronica J. Garcia, Armando E. Giuliano, Xiaojiang Cui. Tissue Regeneration. 2018; doi: 10.5772/intechopen.76997
|
3 |
A Falk, V M Heine, A J Harwood, P F Sullivan, M Peitz, O Brüstle, S Shen, Y-M Sun, J C Glover, D Posthuma, S Djurovic. Modeling psychiatric disorders: from genomic findings to cellular phenotypes. Molecular Psychiatry 2016; 21(9): 1167 doi: 10.1038/mp.2016.89
|
4 |
Kenly Wuputra, Chang-Shen Lin, Ming-Ho Tsai, Chia-Chen Ku, Wen-Hsin Lin, Ya-Han Yang, Kung-Kai Kuo, Kazunari K. Yokoyama. Cancer cell reprogramming to identify the genes competent for generating liver cancer stem cells. Inflammation and Regeneration 2017; 37(1) doi: 10.1186/s41232-017-0041-x
|
5 |
Michael Xavier Doss, Agapios Sachinidis. Current Challenges of iPSC-Based Disease Modeling and Therapeutic Implications. Cells 2019; 8(5): 403 doi: 10.3390/cells8050403
|
6 |
Nancy Palechor-Ceron, Ewa Krawczyk, Aleksandra Dakic, Vera Simic, Hang Yuan, Jan Blancato, Weisheng Wang, Fleesie Hubbard, Yun-Ling Zheng, Hancai Dan, Scott Strome, Kevin Cullen, Bruce Davidson, John F. Deeken, Sujata Choudhury, Peter H. Ahn, Seema Agarwal, Xuexun Zhou, Richard Schlegel, Priscilla A. Furth, Chong-Xian Pan, Xuefeng Liu. Conditional Reprogramming for Patient-Derived Cancer Models and Next-Generation Living Biobanks. Cells 2019; 8(11): 1327 doi: 10.3390/cells8111327
|
7 |
Ignacio Sancho-Martinez, Emmanuel Nivet, Yun Xia, Tomoaki Hishida, Aitor Aguirre, Alejandro Ocampo, Li Ma, Robert Morey, Marie N. Krause, Andreas Zembrzycki, Olaf Ansorge, Eric Vazquez-Ferrer, Ilir Dubova, Pradeep Reddy, David Lam, Yuriko Hishida, Min-Zu Wu, Concepcion Rodriguez Esteban, Dennis O’Leary, Geoffrey M. Wahl, Inder M. Verma, Louise C. Laurent, Juan Carlos Izpisua Belmonte. Establishment of human iPSC-based models for the study and targeting of glioma initiating cells. Nature Communications 2016; 7(1) doi: 10.1038/ncomms10743
|
8 |
Herman Yeger. Come together, right now….. Journal of Cell Communication and Signaling 2015; 9(3): 283 doi: 10.1007/s12079-015-0301-y
|
9 |
Minglin Ou, Min Zhao, Chunhong Li, Donge Tang, Yong Xu, Weier Dai, Weiguo Sui, Yue Zhang, Zhen Xiang, Chune Mo, Hua Lin, Yong Dai. Single-cell sequencing reveals the potential oncogenic expression atlas of human iPSC-derived cardiomyocytes. Biology Open 2021; 10(2) doi: 10.1242/bio.053348
|
10 |
Kátia Maria Sampaio Gomes, Ismael Cabral Costa, Jeniffer Farias dos Santos, Paulo Magno Martins Dourado, Maria Fernanda Forni, Julio Cesar Batista Ferreira. Induced pluripotent stem cells reprogramming: Epigenetics and applications in the regenerative medicine. Revista da Associação Médica Brasileira 2017; 63(2): 180 doi: 10.1590/1806-9282.63.02.180
|
11 |
Yu Seah, Chadi EL Farran, Tushar Warrier, Jian Xu, Yuin-Han Loh. Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and Challenges. International Journal of Molecular Sciences 2015; 16(12): 28614 doi: 10.3390/ijms161226119
|
12 |
D.A.D. Câmara, A.S. Porcacchia, A.S. Costa, R.A. Azevedo, I. Kerkis. Murine melanoma cells incomplete reprogramming using non‐viral vector. Cell Proliferation 2017; 50(4) doi: 10.1111/cpr.12352
|
13 |
Shyam A. Patel. Functional genomic approaches in acute myeloid leukemia: Insights into disease models and the therapeutic potential of reprogramming. Cancer Letters 2022; 533: 215579 doi: 10.1016/j.canlet.2022.215579
|
14 |
Jie chai, Li Han, Jianbo Zhang, Dali Han, Lei Zou, Ze Zhu, Yulong Zhao, Hongliang Guo. Conditional Reprogramming Inducing Clinical Cells Proliferation: New Research Tools in Tumor and Inflammatory-related Diseases. Current Pharmaceutical Design 2020; 26(22): 2657 doi: 10.2174/1381612826666200316155252
|
15 |
Larissa Abbehusen Couto de Carvalho, Simone Leal Tosta dos Santos, Lorena Vieira Sacramento, Vildeman Rodrigues de Almeida, Flávia Caló de Aquino Xavier, Jean Nunes dos Santos, Águida Cristina Gomes Henriques Leitão. Mesenchymal stem cell markers in periodontal tissues and periapical lesions. Acta Histochemica 2020; 122(8): 151636 doi: 10.1016/j.acthis.2020.151636
|
16 |
Zhihan Zhu, Bikram Shah Kalyan, Lukui Chen. Therapeutic potential role of exosomes for ischemic stroke. Brain Science Advances 2019; 5(2): 128 doi: 10.1177/2096595820902588
|
17 |
Hee Seung Lee, Eunyoung Kim, Jinyoung Lee, Seung Joon Park, Ho Kyoung Hwang, Chan Hee Park, Se-Young Jo, Chang Moo Kang, Seung-Mo Hong, Huapyong Kang, Jung Hyun Jo, In Rae Cho, Moon Jae Chung, Jeong Youp Park, Seung Woo Park, Si Young Song, Jung Min Han, Sangwoo Kim, Seungmin Bang. Profiling of conditionally reprogrammed cell lines for in vitro chemotherapy response prediction of pancreatic cancer. EBioMedicine 2021; 65: 103218 doi: 10.1016/j.ebiom.2021.103218
|
18 |
Juliana Lopes, David Arnosti, James E. Trosko, Mei-Hui Tai, Debora Zuccari. Melatonin decreases estrogen receptor binding to estrogen response elements sites on the OCT4 gene in human breast cancer stem cells. Genes & Cancer 2016; 7(5-6): 209 doi: 10.18632/genesandcancer.107
|
19 |
Xuefeng Liu, Ewa Krawczyk, Frank A Suprynowicz, Nancy Palechor-Ceron, Hang Yuan, Aleksandra Dakic, Vera Simic, Yun-Ling Zheng, Praathibha Sripadhan, Chen Chen, Jie Lu, Tung-Wei Hou, Sujata Choudhury, Bhaskar Kallakury, Dean G Tang, Thomas Darling, Rajesh Thangapazham, Olga Timofeeva, Anatoly Dritschilo, Scott H Randell, Christopher Albanese, Seema Agarwal, Richard Schlegel. Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens. Nature Protocols 2017; 12(2): 439 doi: 10.1038/nprot.2016.174
|
20 |
Martin Müller, Patrick C. Hermann, Stefan Liebau, Clair Weidgang, Thomas Seufferlein, Alexander Kleger, Lukas Perkhofer. The role of pluripotency factors to drive stemness in gastrointestinal cancer. Stem Cell Research 2016; 16(2): 349 doi: 10.1016/j.scr.2016.02.005
|
21 |
Anabela Moreira, Michelle Müller, Pedro F. Costa, Yvonne Kohl. Advanced In Vitro Lung Models for Drug and Toxicity Screening: The Promising Role of Induced Pluripotent Stem Cells. Advanced Biology 2022; 6(2) doi: 10.1002/adbi.202101139
|
22 |
Nur Yucer, Rodney Ahdoot, Michael J. Workman, Alexander H. Laperle, Maria S. Recouvreux, Kathleen Kurowski, Diana J. Naboulsi, Victoria Liang, Ying Qu, Jasmine T. Plummer, Simon A. Gayther, Sandra Orsulic, Beth Y. Karlan, Clive N. Svendsen. Human iPSC-derived fallopian tube organoids with BRCA1 mutation recapitulate early-stage carcinogenesis. Cell Reports 2021; 37(13): 110146 doi: 10.1016/j.celrep.2021.110146
|
23 |
Hana Hříbková, Jana Zelinková, Yuh-Man Sun. Progress in human pluripotent stem cell-based modeling systems for neurological diseases. Neurogenesis 2017; 4(1): e1324258 doi: 10.1080/23262133.2017.1324258
|
24 |
Yue Hu, Jochen Gaedcke, Georg Emons, Tim Beissbarth, Marian Grade, Peter Jo, Meredith Yeager, Stephen J. Chanock, Hendrik Wolff, Jordi Camps, B. Michael Ghadimi, Thomas Ried. Colorectal cancer susceptibility loci as predictive markers of rectal cancer prognosis after surgery. Genes, Chromosomes and Cancer 2018; 57(3): 140 doi: 10.1002/gcc.22512
|
25 |
Elisabete Nascimento-Gonçalves, Rita Ferreira, Paula A. Oliveira, Bruno Jorge Antunes Colaço. An Overview of Current Alternative Models for Use in the Context of Prostate Cancer Research. Alternatives to Laboratory Animals 2020; 48(2): 58 doi: 10.1177/0261192920929701
|
26 |
Javad Amini Mahabadi, Hamed Sabzalipour, Hassan Hassani Bafrani, Seyed Mohammad Gheibi Hayat, Hossein Nikzad. Application of induced pluripotent stem cell and embryonic stem cell technology to the study of male infertility. Journal of Cellular Physiology 2018; 233(11): 8441 doi: 10.1002/jcp.26757
|
27 |
Matin Chehelgerdi, Fereshteh Behdarvand Dehkordi, Mohammad Chehelgerdi, Hamidreza Kabiri, Hosein Salehian-Dehkordi, Mohammad Abdolvand, Sharareh Salmanizadeh, Mohsen Rashidi, Anoosha Niazmand, Saba Ahmadi, Sara Feizbakhshan, Saber Kabiri, Nasimeh Vatandoost, Tayebeh Ranjbarnejad. Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy. Molecular Cancer 2023; 22(1) doi: 10.1186/s12943-023-01873-0
|
28 |
Alvaro Muñoz-López, Damià Romero-Moya, Cristina Prieto, Verónica Ramos-Mejía, Antonio Agraz-Doblas, Ignacio Varela, Marcus Buschbeck, Anna Palau, Xonia Carvajal-Vergara, Alessandra Giorgetti, Anthony Ford, Majlinda Lako, Isabel Granada, Neus Ruiz-Xivillé, Sandra Rodríguez-Perales, Raul Torres-Ruíz, Ronald W. Stam, Jose Luis Fuster, Mario F. Fraga, Mahito Nakanishi, Gianni Cazzaniga, Michela Bardini, Isabel Cobo, Gustavo F. Bayon, Agustin F. Fernandez, Clara Bueno, Pablo Menendez. Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency. Stem Cell Reports 2016; 7(4): 602 doi: 10.1016/j.stemcr.2016.08.013
|
29 |
Teresa de Souza Fernandez, André Luiz Mencalha, Cecília de Souza Fernandez. Recent Advances in Stem Cells. Stem Cell Biology and Regenerative Medicine 2016; : 131 doi: 10.1007/978-3-319-33270-3_7
|
30 |
Abdul M. Mondal, Ai-Hong Ma, Guangzhao Li, Ewa Krawczyk, Ruan Yuan, Jie Lu, Richard Schlegel, Lambros Stamatakis, Keith J. Kowalczyk, George K. Philips, Chong-Xian Pan, Xuefeng Liu. Fidelity of a PDX-CR model for bladder cancer. Biochemical and Biophysical Research Communications 2019; 517(1): 49 doi: 10.1016/j.bbrc.2019.06.165
|
31 |
Zhihan Zhu, Bikram Shah Kalyan, Lukui Chen. Therapeutic potential role of exosomes for ischemic stroke. Brain Science Advances 2019; 5(2): 128 doi: 10.1177/2096595820902588
|
32 |
Satish Kumar, John Blangero, Joanne E. Curran. Disease Gene Identification. Methods in Molecular Biology 2018; 1706: 17 doi: 10.1007/978-1-4939-7471-9_2
|
33 |
Sahira Syamimi Ahmad Zawawi, Elyn Amiela Salleh, Marahaini Musa. Spheroids and organoids derived from colorectal cancer as tools for in vitro drug screening. Exploration of Targeted Anti-tumor Therapy 2024; 5(2): 409 doi: 10.37349/etat.2024.00226
|
34 |
L Charaf, F-X Mahon, I Lamrissi-Garcia, I Moranvillier, F Beliveau, B Cardinaud, S Dabernat, H de Verneuil, F Moreau-Gaudry, A Bedel. Effect of tyrosine kinase inhibitors on stemness in normal and chronic myeloid leukemia cells. Leukemia 2017; 31(1): 65 doi: 10.1038/leu.2016.154
|